ADMP has.......
2 Symjepi (epipens) currently approved by FDA and marketed by our partner USWORLDMED out of Kentucky..WE offer cheapest epipens 2 for 99.00 both SR.and JR for adults and children.
We are awaiting FDA decision for ZIMHI Full FDA approval that can come at anytime,anyday between now and Nov 12 2021..3rd time we are seeking for an FDA full approval.
So that gives us 3 drugs for income stream....once ZIMHI is approved.
Lastly, Tempol our licensed drug from Biomed last year we are ready to start our Covid Trial Aug 25 2021 or sooner.
Tempol Phase 3 trial for Tempol Topical Gel is near ready to start also soon and will be done in Penn State..
Both Covid Trial and Tempol Gel Trial will get funded fully or most of it anyways....
If Tempol Capsules are approved under FDA's EUA and ZIMHI Is approved also over the next 3-4 months ....
ADMP could have these 2 ADDITIONAL DRUGS added for marketing along with our two epipens......
SO we have 2 in the bag already, 1 pending per FDA decision,one Tempol Drug/Covid capsules for treating early and late Covid Symptoms...
That is why it is a BO target imo.....ALL THIS for 1.21 as of close Fri.Night.....Tic Toc....No Pump needed...Science speaks and will speak for itself......
GO ADMP.......Thanks Roll
News 
Market Data 
Discover 
